$544.72
0.21% yesterday
Nasdaq, Dec 12, 10:11 pm CET
ISIN
US46120E6023
Symbol
ISRG
Sector

Intuitive Surgical Stock price

$544.72
+7.65 1.42% 1M
+116.62 27.24% 6M
+207.36 61.47% YTD
+224.01 69.85% 1Y
+204.36 60.04% 3Y
+351.06 181.28% 5Y
+488.86 875.09% 10Y
Nasdaq, Closing price Thu, Dec 12 2024
+1.12 0.21%
ISIN
US46120E6023
Symbol
ISRG
Sector

Key metrics

Market capitalization $194.02b
Enterprise Value $189.88b
P/E (TTM) P/E ratio 87.55
EV/FCF (TTM) EV/FCF 324.03
EV/Sales (TTM) EV/Sales 24.14
P/S ratio (TTM) P/S ratio 24.66
P/B ratio (TTM) P/B ratio 12.45
Revenue growth (TTM) Revenue growth 14.83%
Revenue (TTM) Revenue $7.87b
EBIT (operating result TTM) EBIT $2.06b
Free Cash Flow (TTM) Free Cash Flow $586.00m
Cash position $4.23b
EPS (TTM) EPS $6.22
P/E forward 90.66
P/S forward 23.81
EV/Sales forward 23.30
Short interest 0.98%
Show more

Create a Free Account to create an Intuitive Surgical alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Intuitive Surgical Stock Analysis

Analyst Opinions

32 Analysts have issued a Intuitive Surgical forecast:

22x Buy
69%
10x Hold
31%

Analyst Opinions

32 Analysts have issued a Intuitive Surgical forecast:

Buy
69%
Hold
31%

Financial data from Intuitive Surgical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
7,867 7,867
15% 15%
100%
- Direct Costs 2,598 2,598
13% 13%
33%
5,269 5,269
16% 16%
67%
- Selling and Administrative Expenses 1,643 1,643
11% 11%
21%
- Research and Development Expense 1,111 1,111
13% 13%
14%
2,516 2,516
20% 20%
32%
- Depreciation and Amortization 451 451
10% 10%
6%
EBIT (Operating Income) EBIT 2,064 2,064
22% 22%
26%
Net Profit 2,243 2,243
48% 48%
29%

In millions USD.

Don't miss a Thing! We will send you all news about Intuitive Surgical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Intuitive Surgical Stock News

Neutral
GlobeNewsWire
7 days ago
Analysis included 230 studies—a mix of randomized, prospective, and database research SUNNYVALE, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:ISRG) The peer-reviewed Annals of Surgery published a meta-analysis of 30-day surgical outcomes across seven oncological surgical procedures, comparing robotic, laparoscopic, and open surgical approaches.
Positive
The Motley Fool
15 days ago
Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't automatically worth investing in just because they provide essential medical services.
Positive
Seeking Alpha
24 days ago
Intuitive Surgical has become a leader for numerous procedures, and we expect it to continue its growth. The company is seeing double-digit growth both in systems and consumables driving revenue. We expect the company to continue its growth and returns making it a valuable investment.
More Intuitive Surgical News

Company Profile

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Gary Guthart
Employees 13,676
Founded 1995
Website www.intuitive.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today